In a first, gene therapy halts a fatal brain disease:

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.

ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024

In a first, gene therapy halts a fatal brain disease:

Context:

  • A new study indicates that gene therapy can hold off Adrenoleukodystrophy (ALD), a rare disorder, without side effects, but only if it is begun when the only signs of deterioration are changes in brain scans.
  • The key to making the therapy work is human Immunodeficiency virus (HIV).

Was the study successful?

  • The study involved 17 boys aged 4 to 13. All got gene therapy. Two years later, 15 were functioning normally without obvious symptoms.
  • The study opened up new avenues for using gene therapy to treat brain diseases.

What is ALD?

  • A mutated gene causes a rare disorder, adrenoleukodystrophy, or ALD.
  • Nerve cells in the brain die, and in a few short years, children lose the ability to walk or talk.
  • They become unable to eat without a feeding tube, to see, hear or think. They usually die within five years of diagnosis.
  • The disease strikes about one in 20,000 boys; symptoms first occur at an average age of 7

Is there any cure of the disorder?

  • The only treatment is a bone-marrow transplant, if a compatible donor can be found or a transplant with cord blood, if it was saved at birth.
  • These transplants are difficult and dangerous therapy, with a mortality rate as high as 20%. Some who survive are left with lifelong disabilities.
Print Friendly and PDF
Blog
Academy
Community